Your browser doesn't support javascript.
loading
Guía para elaborar una estrategia de comunicación de riesgos sobre las vacunas contra la COVID-19 / Guía para elaborar una estrategia de comunicación de riesgos sobre las vacunas contra la COVID-19 / Guide for the preparation of a risk communication strategy for COVID-19 vaccines: A Resource for the countries of the Americas
Washington; Organización Panamericana de la Salud; mar. 02, 2021. 28 p. ilus.
Non-conventional in English, Spanish, Portuguese | LILACS | ID: biblio-1150961
Responsible library: BR1.1
RESUMEN
Todos os países do mundo formularam planos de resposta para enfrentar a pandemia da COVID-19. No entanto, os desafios impostos pela doença os obrigam a aprender e adaptar-se constantemente. Cada vez mais é necessário reforçar o componente de comunicação de riscos como uma ferramenta essencial para transmitir à população, da devida forma, todas as informações sobre o processo de imunização, desde os testes clínicos e a produção de novas vacinas, até a adoção, distribuição e priorização dos grupos aos quais serão administradas uma ou mais vacinas ­ dependendo da definição e disponibilidade de cada país ­, bem como sobre o acesso universal às vacinas, após os grupos prioritários terem sido imunizados. A Organização Pan-Americana da Saúde, em seu esforço constante e permanente para apoiar os países das Américas, apresenta este documento para facilitar a formulação de uma estratégia de comunicação de riscos e participação comunitária (CRPC) para a vacinação contra o SARS-CoV-2. O intuito é contribuir para o fortalecimento das capacidades de comunicação e planejamento dos ministérios e secretarias de saúde, bem como de outros órgãos responsáveis pela comunicação na área das novas vacinas contra a COVID-19 nas Américas.
ABSTRACT
All countries around the world have developed response plans to tackle the COVID-19 pandemic. However, the challenges presented by the disease require constant learning and adaptation. It is increasingly necessary to strengthen the risk communication component as an essential tool for providing the population with all of the necessary information about the immunization process. This ranges from clinical trials and the production of new vaccines to the introduction, distribution, and prioritization of groups that need one or more vaccines­according to each country's definitions and vaccine availability. It also includes universal access to vaccines, once the priority groups have been immunized. PAHO, in its constant, ongoing effort to support the countries of the Americas, is making this document available to facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of health and other agencies in charge of communicating about new COVID-19 vaccines in the Americas.
Subject(s)
Full text: Available Collection: International databases Health context: SDG3 - Target 3.8 Achieve universal access to health / Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Multisectoral Coordination / Goal 5: Medicines, vaccines and health technologies / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia Database: LILACS Main subject: Pneumonia, Viral / Viral Vaccines / Immunization Programs / Coronavirus Infections / Health Communication / Pandemics / Betacoronavirus Type of study: Etiology study / Practice guideline / Risk factors Limits: Humans Language: English / Spanish / Portuguese Year: 2021 Document type: Non-conventional
Full text: Available Collection: International databases Health context: SDG3 - Target 3.8 Achieve universal access to health / Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Multisectoral Coordination / Goal 5: Medicines, vaccines and health technologies / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia Database: LILACS Main subject: Pneumonia, Viral / Viral Vaccines / Immunization Programs / Coronavirus Infections / Health Communication / Pandemics / Betacoronavirus Type of study: Etiology study / Practice guideline / Risk factors Limits: Humans Language: English / Spanish / Portuguese Year: 2021 Document type: Non-conventional
...